Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer.

Chen SA, Schuster DM, Mister D, Liu T, Godette K, Torres MA.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):309-14. doi: 10.1016/j.ijrobp.2012.06.008.

PMID:
23312271
2.

Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer.

Muijs CT, Beukema JC, Woutersen D, Mul VE, Berveling MJ, Pruim J, van der Jagt EJ, Hospers GA, Groen H, Plukker JT, Langendijk JA.

Radiother Oncol. 2014 Nov;113(2):188-92. doi: 10.1016/j.radonc.2014.10.016. Epub 2014 Nov 29.

PMID:
25467002
3.

Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.

Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.

Nucl Med Commun. 2012 Jun;33(6):591-6. doi: 10.1097/MNM.0b013e3283516716.

PMID:
22334135
4.

Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.

Nakajima N, Kataoka M, Sugawara Y, Ochi T, Kiyoto S, Ohsumi S, Mochizuki T.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):738-46. doi: 10.1016/j.ijrobp.2013.08.001. Epub 2013 Sep 21.

PMID:
24064322
5.

Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs.

Walker GV, Niikura N, Yang W, Rohren E, Valero V, Woodward WA, Alvarez RH, Lucci A Jr, Ueno NT, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1381-6. doi: 10.1016/j.ijrobp.2011.10.040. Epub 2012 Jan 26.

PMID:
22284689
6.

Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.

Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Strom EA, Tereffe W, Woodward WA, Tucker SL, Hunt KK, Hortobagyi GN, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1296-302. doi: 10.1016/j.ijrobp.2009.12.011. Epub 2010 May 14.

PMID:
20472353
7.

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.

Aukema TS, Rutgers EJ, Vogel WV, Teertstra HJ, Oldenburg HS, Vrancken Peeters MT, Wesseling J, Russell NS, Valdés Olmos RA.

Eur J Surg Oncol. 2010 Apr;36(4):387-92. doi: 10.1016/j.ejso.2009.11.009. Epub 2009 Dec 3.

PMID:
19962268
8.

[¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.

Terezakis SA, Hunt MA, Kowalski A, McCann P, Schmidtlein CR, Reiner A, Gönen M, Kirov AS, Gonzales AM, Schöder H, Yahalom J.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):615-22. doi: 10.1016/j.ijrobp.2010.06.044. Epub 2010 Oct 8.

PMID:
20933343
9.

A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.

Ding X, Li H, Wang Z, Huang W, Li B, Zang R, Sun H, Yi Y.

Technol Cancer Res Treat. 2013 Jun;12(3):251-7. doi: 10.7785/tcrt.2012.500310. Epub 2012 Dec 26.

PMID:
23289475
10.

Value of F-18 FDG PET/CT in detection and prognostication of isolated extra-axillary lymph node recurrences in postoperative breast cancer.

Oh JK, Chung YA, Kim YS, Jeon HM, Kim SH, Park YH, Chung SK.

Biomed Mater Eng. 2014;24(1):1173-84. doi: 10.3233/BME-130918.

PMID:
24212011
11.

18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.

García Vicente AM, Soriano Castrejón A, Relea Calatayud F, Muñoz Madero V, Molina Garrido MJ, León Martín AA, Cordero García JM, Pilkington Woll JP, Chacón López-Muñiz I, Palomar Muñoz A.

Rev Esp Med Nucl Imagen Mol. 2012 Nov-Dec;31(6):308-14. doi: 10.1016/j.remn.2011.12.001. Epub 2012 Mar 19.

12.

(18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy.

Sura S, Greco C, Gelblum D, Yorke ED, Jackson A, Rosenzweig KE.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1397-402. doi: 10.1016/j.ijrobp.2007.08.052.

13.
14.

18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.

Haug AR, Tiega Donfack BP, Trumm C, Zech CJ, Michl M, Laubender RP, Uebleis C, Bartenstein P, Heinemann V, Hacker M.

J Nucl Med. 2012 Mar;53(3):371-7. doi: 10.2967/jnumed.111.096230. Epub 2012 Feb 13.

15.

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.

Groheux D, Hindié E, Delord M, Giacchetti S, Hamy AS, de Bazelaire C, de Roquancourt A, Vercellino L, Toubert ME, Merlet P, Espié M.

J Natl Cancer Inst. 2012 Dec 19;104(24):1879-87. doi: 10.1093/jnci/djs451. Epub 2012 Dec 12.

16.

A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies.

Terezakis SA, Schöder H, Kowalski A, McCann P, Lim R, Turlakov A, Gonen M, Barker C, Goenka A, Lovie S, Yahalom J.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):376-83. doi: 10.1016/j.ijrobp.2014.02.006. Epub 2014 Apr 11.

18.

Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer.

Shirvani SM, Komaki R, Heymach JV, Fossella FV, Chang JY.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e91-7. doi: 10.1016/j.ijrobp.2010.12.072. Epub 2011 Apr 12.

19.

Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.

Ohsumi S, Inoue T, Kiyoto S, Hara F, Takahashi M, Takabatake D, Takashima S, Aogi K, Takashima S.

Breast Cancer Res Treat. 2011 Nov;130(1):267-72. doi: 10.1007/s10549-011-1561-8. Epub 2011 May 13.

PMID:
21590272
20.

The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.

Gabos Z, Thoms J, Ghosh S, Hanson J, Deschênes J, Sabri S, Abdulkarim B.

Breast Cancer Res Treat. 2010 Nov;124(1):187-94. doi: 10.1007/s10549-010-1135-1. Epub 2010 Sep 3.

PMID:
20814819

Supplemental Content

Support Center